Non-Immune Hydrops, Hypotonia, Encephalopathy, and Liver Failure with Novel Compound Heterozygous AHCY Mutations

A late-preterm infant with a prenatal diagnosis of non-immune hydrops was born with hypotonia, poor respiratory effort, chylothorax, encephalopathy, coagulopathy, progressive hepatic failure, and refractory pulmonary hypertension. Life support was withdrawn at 7 days of life due to multisystem organ failure. Rapid whole exome sequencing revealed novel compound heterozygous mutations in the gene encoding S-adenosylhomocysteine hydrolase (AHCY); each novel variant was carried by an asymptomatic parent. Reports of neonates with other AHCY mutations describe a pathology of varying severity. AHCY mutations should be considered when seeking an etiology for neonates with the combination of non-immune hydrops, hypotonia, encephalopathy, and liver failure.

[1]  H. Blom,et al.  Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders , 2016, Journal of Inherited Metabolic Disease.

[2]  H. Blom,et al.  Adenosine kinase deficiency: expanding the clinical spectrum and evaluating therapeutic options , 2016, Journal of Inherited Metabolic Disease.

[3]  Jonathan C. Cohen,et al.  Adult-onset liver disease and hepatocellular carcinoma in S-adenosylhomocysteine hydrolase deficiency. , 2015, Molecular genetics and metabolism.

[4]  R. Hennekam,et al.  Etiology of non‐immune hydrops fetalis: An update , 2015, American journal of medical genetics. Part A.

[5]  J. Zeman,et al.  Clinical picture of S-adenosylhomocysteine hydrolase deficiency resembles phosphomannomutase 2 deficiency. , 2012, Molecular genetics and metabolism.

[6]  M. Radoš,et al.  S-adenosylhomocysteine hydrolase deficiency: two siblings with fetal hydrops and fatal outcomes , 2010, Journal of Inherited Metabolic Disease.

[7]  N. Nakić,et al.  S‐adenosylhomocysteine hydrolase (AHCY) deficiency: Two novel mutations with lethal outcome , 2009, Human mutation.

[8]  R. Clark,et al.  Hydrops Fetalis: A Retrospective Review of Cases Reported to a Large National Database and Identification of Risk Factors Associated With Death , 2007, Pediatrics.

[9]  H. Blom,et al.  Effect of genetic variation in the human S-adenosylhomocysteine hydrolase gene on total homocysteine concentrations and risk of recurrent venous thrombosis , 2004, European Journal of Human Genetics.

[10]  I. Pogribny,et al.  S-adenosylhomocysteine hydrolase deficiency in a human: A genetic disorder of methionine metabolism , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Barsh,et al.  The mouse lethal nonagouti (a(x)) mutation deletes the S‐adenosylhomocysteine hydrolase (Ahcy) gene. , 1994, The EMBO journal.